Incomplete statistics from VCBeat identified 21 financing events in China's healthcare sector between October 27 and 31, 2025 (excluding IPOs and private placements).
The largest disclosed transaction was Maxvax's Series D round exceeding 400 million yuan, jointly invested by IDG Capital, Shenzhen Capital Group and Ruipu Pharmaceutical.


